A Quantitative Chemical Proteomics Approach to Profile the Specific Cellular Targets of Andrographolide, a Promising Anticancer Agent That Suppresses Tumor Metastasis*

Drug target identification is a critical step toward understanding the mechanism of action of a drug, which can help one improve the drug's current therapeutic regime and expand the drug's therapeutic potential. However, current in vitro affinity-chromatography-based and in vivo activity-based protein profiling approaches generally face difficulties in discriminating specific drug targets from nonspecific ones. Here we describe a novel approach combining isobaric tags for relative and absolute quantitation with clickable activity-based protein profiling to specifically and comprehensively identify the protein targets of andrographolide (Andro), a natural product with known anti-inflammation and anti-cancer effects, in live cancer cells. We identified a spectrum of specific targets of Andro, which furthered our understanding of the mechanism of action of the drug. Our findings, validated through cell migration and invasion assays, showed that Andro has a potential novel application as a tumor metastasis inhibitor. Moreover, we have unveiled the target binding mechanism of Andro with a combination of drug analog synthesis, protein engineering, and mass-spectrometry-based approaches and determined the drug-binding sites of two protein targets, NF-κB and actin.

[1]  M. Chatterjee,et al.  Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent. , 2010, Bioorganic & medicinal chemistry letters.

[2]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[3]  H. Overkleeft,et al.  Bioorthogonal chemistry: applications in activity-based protein profiling. , 2011, Accounts of chemical research.

[4]  Shao Q Yao,et al.  Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. , 2012, Journal of the American Chemical Society.

[5]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[6]  Jeremy J. W. Chen,et al.  A Novel Function of YWHAZ/β-Catenin Axis in Promoting Epithelial–Mesenchymal Transition and Lung Cancer Metastasis , 2012, Molecular Cancer Research.

[7]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[8]  M. Bogyo,et al.  Activity-based probes as a tool for functional proteomic analysis of proteases , 2008, Expert review of proteomics.

[9]  Guo-Dong Lu,et al.  Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation , 2008, Molecular Cancer Therapeutics.

[10]  W. Wong,et al.  A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-kb Pathway , 2022 .

[11]  S. Sieber,et al.  Electrophilic natural products and their biological targets. , 2012, Natural product reports.

[12]  J. Geng,et al.  Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis. , 2007, Cell research.

[13]  P. Nordlund,et al.  Molecular and Structural Basis for Redox Regulation of β-Actin , 2007 .

[14]  Liang Wang,et al.  Design, synthesis and antibacterial activity of novel andrographolide derivatives. , 2010, Bioorganic & medicinal chemistry.

[15]  E. Hu,et al.  Molecular Cloning and Characterization of Profilin-3: A Novel Cytoskeleton-Associated Gene Expressed in Rat Kidney and Testes , 2001, Nephron Experimental Nephrology.

[16]  C. Ong,et al.  Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. , 2010, Biochemical pharmacology.

[17]  Hwee Tong Tan,et al.  Quantitative and Temporal Proteome Analysis of Butyrate-treated Colorectal Cancer Cells*S , 2008, Molecular & Cellular Proteomics.

[18]  P. Nordlund,et al.  Molecular and structural basis for redox regulation of beta-actin. , 2007, Journal of molecular biology.

[19]  J. Condeelis,et al.  Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.

[20]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[21]  Thomas Böttcher,et al.  Natural products and their biological targets: proteomic and metabolomic labeling strategies. , 2010, Angewandte Chemie.

[22]  O. Llorca,et al.  Addition of electrophilic lipids to actin alters filament structure. , 2006, Biochemical and biophysical research communications.

[23]  M. Stevens,et al.  Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis , 2008, British journal of pharmacology.

[24]  M. Matter,et al.  R-Ras Regulates Migration through an Interaction with Filamin A in Melanoma Cells , 2010, PloS one.

[25]  Johannes Griss,et al.  The Proteomics Identifications (PRIDE) database and associated tools: status in 2013 , 2012, Nucleic Acids Res..

[26]  B. Cravatt,et al.  Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.

[27]  Yuichiro Hirayama,et al.  Development of highly cytotoxic and actin-depolymerizing biotin derivatives of aplyronine A. , 2011, Angewandte Chemie.

[28]  Anna E Speers,et al.  Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.

[29]  G. Aldini,et al.  Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. , 2007, Biochemistry.

[30]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[31]  J. Geng,et al.  Andrographolide inhibits NF-κB activation and attenuates neointimal hyperplasia in arterial restenosis , 2007, Cell Research.

[32]  L. Landino Protein thiol modification by peroxynitrite anion and nitric oxide donors. , 2008, Methods in enzymology.

[33]  Steven A Carr,et al.  Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.

[34]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[35]  Benedikt M Kessler,et al.  Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy. , 2003, Angewandte Chemie.

[36]  H. Krutzsch,et al.  Identification of heat shock protein 60 as a molecular mediator of α3β1 integrin activation , 2002 .

[37]  Yi-Chieh Lee,et al.  Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression. , 2009, Chemico-biological interactions.

[38]  Benjamin F. Cravatt,et al.  Activity-based protein profiling for biochemical pathway discovery in cancer , 2010, Nature Reviews Cancer.

[39]  M. Wenk,et al.  Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities. , 2010, Journal of the American Chemical Society.

[40]  B. Chait,et al.  Quantitative chemical proteomics approach to identify post-translational modification-mediated protein-protein interactions. , 2012, Journal of the American Chemical Society.

[41]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[42]  Siyuan Zhang,et al.  Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. , 2006, Biochemical pharmacology.

[43]  Matthew Bogyo,et al.  Application of activity-based probes to the study of enzymes involved in cancer progression. , 2008, Current opinion in genetics & development.

[44]  A. Tanaka [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[45]  D. Fan,et al.  MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer , 2011, PloS one.

[46]  J. Puzas,et al.  Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. , 2000, Cancer research.

[47]  Hua Guo,et al.  Expression of Nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells , 2012, Journal of Biomedical Science.

[48]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[49]  Wong Cheng Lee,et al.  High-performance graphene-titania platform for detection of phosphopeptides in cancer cells. , 2012, Analytical chemistry.

[50]  H. Waldmann,et al.  Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actin. , 2010, Journal of the American Chemical Society.

[51]  J. Cox,et al.  Proteomics strategy for quantitative protein interaction profiling in cell extracts , 2009, Nature Methods.

[52]  S. Sieber,et al.  Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus. , 2008, Journal of the American Chemical Society.

[53]  Yaxue Zhao,et al.  Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. , 2012, Nature chemical biology.

[54]  J. Geng,et al.  Andrographolide Attenuates Inflammation by Inhibition of NF-κB Activation through Covalent Modification of Reduced Cysteine 62 of p501 , 2004, The Journal of Immunology.

[55]  E. Génot,et al.  Binding of filamentous actin and winding into fibrillar aggregates by the polyphenolic C-glucosidic ellagitannin vescalagin. , 2011, Angewandte Chemie.

[56]  J. M. Babu,et al.  Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents. , 2004, Bioorganic & medicinal chemistry letters.

[57]  Vishal A. Verma,et al.  Actin is the primary cellular receptor of bistramide A , 2005, Nature chemical biology.

[58]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[59]  Hwee Tong Tan,et al.  Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. , 2011, Journal of proteome research.